Estatinas, Riesgo de Hepatotoxicidad y Enfermedad Hepática.
Este artículo tal y como se muestra en la página de la revista (https://www.sapd.es/rapd/2007/30/3) cuenta con una Licencia CC BY-NC-ND 4.0Las estatinas son fármacos ampliamente utilizados para la reducción del colesterol y la prevención de enfermedades ...
Cueto-Galán, Raquel +4 more
core
ROLE OF STATINS IN CIRRHOTIC PORTAL HYPERTENSION: META-ANALYSIS OF RANDOMIZED STUDIES. [PDF]
Moreno MOA +6 more
europepmc +1 more source
Características clínicas asociadas a niveles elevados de lipoproteína(a) en pacientes atendidos por riesgo vascular. [PDF]
Rubio-Serrano J +2 more
europepmc +1 more source
Achieving LDL-Cholesterol Goals: Can Implementation Science Save Us? [PDF]
Cesena FY.
europepmc +1 more source
[EUROPREV Forum Madrid 2026: «Towards a safe, effective and person-centered prevention»]. [PDF]
Camarelles F +4 more
europepmc +1 more source
Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis - 2025. [PDF]
Rached FH +39 more
europepmc +1 more source
[A web resource for the critical evaluation of medical information in primary care]. [PDF]
Pérez Franco B.
europepmc +1 more source
[Role of statins in clinical evolution of octogenarian patients admitted due to COVID-19]. [PDF]
Jiménez Martínez C +7 more
europepmc +1 more source
Long-term mortality and predictive score performance in Brazilian atherosclerotic renovascular disease patients. [PDF]
Salome JG +9 more
europepmc +1 more source
From Cholesterol Metabolism to Comprehensive Lipid Management and Crosstalk of Inflammation: Expanding the Frontiers of Cardiovascular Prevention. [PDF]
Vilela E, Bettencourt N.
europepmc +1 more source

